Search Results

You are looking at 11 - 20 of 52 items for :

  • "Geriatric Oncology" x
  • Refine by Access: All x
Clear All
Full access

Elizabeth R. Kessler, Janet B. Kukreja, Christopher L. Geiger, and Stacy M. Fischer

include treatment planning from multiple disciplines, such as surgical urologic oncology, medical oncology, and radiation oncology. As clinicians develop treatment plans, considering a geriatric oncology perspective may enhance patient care and influence

Full access

Supriya G. Mohile, Allison Magnuson, Chintan Pandya, Carla Velarde, Paul Duberstein, Arti Hurria, Kah Poh Loh, Megan Wells, Sandy Plumb, Nikesha Gilmore, Marie Flannery, Marsha Wittink, Ronald Epstein, Charles E. Heckler, Michelle Janelsins, Karen Mustian, Judith O. Hopkins, Jane Liu, Srihari Peri, and William Dale

training, and therefore common aging-related conditions that influence outcomes are rarely detected. 13 – 16 In this study, community oncologists were recruited to participate in 2 nationwide, geriatric oncology clinical trials in the University of

Full access

Rebecca A. Nelson, Enrique Soto-Perez-de-Celis, Rowan T. Chlebowski, Mara Schonberg, Joanne Mortimer, Kathy Pan, Lifang Hou, Marian L. Neuhouser, Kerryn W. Reding, Nazmus Saquib, Jean Wactawski-Wende, Emily Wolfson, Mina S. Sedrak, and Laura Kruper

’s overall health and functional well-being. The Schonberg index, 2 which predicts all-cause 10-year mortality risk, is one of the preferred methods for risk assessment described by the ASCO geriatric oncology guidelines. 3 The Schonberg index incorporates

Full access

June M. McKoy, Peggy S. Burhenn, Ilene S. Browner, Kari L. Loeser, Katrina M. Tulas, Megan R. Oden, and Randall W. Rupper

should therefore be incorporated into the clinical plan of care. The Comprehensive Geriatric Assessment (CGA) is one such tool that can be recruited within the geriatric oncology domain to assess functional status (cognitive and physical), nutritional

Full access

Tammy T. Hshieh, Clark DuMontier, Timothy Jaung, Nupur E. Bahl, Chelsea E. Hawley, Lee Mozessohn, Richard M. Stone, Robert J. Soiffer, Jane A. Driver, and Gregory A. Abel

oncologists and geriatricians to assist with the identification of medications often encountered in oncology practice that carry risks for older patients. 33 We translated the list into the Geriatric Oncology Potentially Inappropriate Medications (GO

Full access

Robert W. Carlson, Susan Moench, Arti Hurria, Lodovico Balducci, Harold J. Burstein, Lori J. Goldstein, William J. Gradishar, Kevin S. Hughes, Mohammad Jahanzeb, Stuart M. Lichtman, Lawrence B. Marks, Joan S. McClure, Beryl McCormick, Lisle M. Nabell, Lori J. Pierce, Mary Lou Smith, Neal S. Topham, Tiffany A. Traina, John H. Ward, and Eric P. Winer

older woman. A total of 18 task force members represented medical oncology, radiation oncology, surgical oncology, geriatric oncology, geriatrics, plastic surgery, and patient advocacy. All task force members were identified and invited solely by NCCN. A

Full access

Efrat Dotan and Louise C. Walter

On November 7, 2018, the NCCN Older Adult Oncology Panel and the geriatric oncology community as a whole lost a tremendous leader, mentor, and scientist with the passing of Arti Hurria, MD, in a tragic accident. As the NCCN Older Adult Panel mourns

Full access

June M. McKoy

?” That was so like Dr. Hurria: to be inclusive, enthusiastic, and generous. And that was the last correspondence we had. On November 7, 2018, Dr. Arti Hurria, George Tsai Family Chair in Geriatric Oncology, Director of the Center for Cancer and Aging at

Full access

Armin Shahrokni, Bella Marie Vishnevsky, Brian Jang, Saman Sarraf, Koshy Alexander, Soo Jung Kim, Robert Downey, Anoushka Afonso, and Beatriz Korc-Grodzicki

survival. 8 , 10 – 12 Furthermore, the ASA system is easy to use and has broad awareness and acceptance. 8 , 9 However, its use in the geriatric oncology population has been questioned. In one study of 178 patients aged ≥70 years who underwent elective

Full access

Matilde Corianò, Matteo Armillotta, and Nicolò Matteo Luca Battisti

Nicolò Matteo Luca Battisti, MD, MD(Res), is a Consultant Medical Oncologist in the Breast Unit of The Royal Marsden Hospital, London, UK. His focuses of clinical and research interest are breast oncology, geriatric oncology and inequalities in cancer